Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Midas B. Mulder, PharmD"'
Autor:
Midas B. Mulder, PharmD, Bart van Hoek, MD, PhD, Wojtek G. Polak, MD, PhD, Ian P.J. Alwayn, MD, PhD, Brenda C.M. de Winter, PharmD, PhD, Sarwa Darwish Murad, MD, PhD, Elke Verhey-Hart, BSc, Lara Elshove, MSc, Nicole S. Erler, Dipl-Stat, PhD, Dennis A. Hesselink, MD, PhD, Caroline M. den Hoed, MD, PhD, Herold J. Metselaar, MD, PhD
Publikováno v:
Transplantation Direct, Vol 10, Iss 4, p e1612 (2024)
Background. The aim of this open-label, multicenter, randomized controlled study was to investigate whether the life cycle pharma (LCP)-tacrolimus compared with the extended-release (ER)-tacrolimus formulation results in a difference in the prevalenc
Externí odkaz:
https://doaj.org/article/e000db20ac504b629c8bfe70cc940d02
